Mereo BioPharma Group Plc (MREO)

0.291 0.00 (0.00%) USD  |  NASDAQ  |  Aug 24, 16:00
0.291 0.00 (0.00%) After-Hours: 20:00
More

Mereo BioPharma Group EPS Diluted (Quarterly) : -0.0437 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 -0.0437
March 31, 2026 -0.0418
December 31, 2025 -0.0461
September 30, 2025 -0.0436
June 30, 2025 -0.0925
Date Value
March 31, 2025 -0.0825
December 31, 2024 -0.045
September 30, 2024 -0.0984
June 30, 2024 -0.0862
March 31, 2024 -0.0639

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc -1.007
BioNTech SE -3.799
Silence Therapeutics Plc -0.0866
Autolus Therapeutics Plc -0.1472

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -7.018M
Total Expenses (Quarterly) 7.018M
Enterprise Value 17.27M
Earnings Yield -60.21%
Normalized Earnings Yield -61.00